Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Reistone Biopharma

Request full access

Focusing on rapidly developing innovative medicines through global collaborations within Research and Development

Huangpu, ChinaFounded 2018Biotech & Life Sciences

About Reistone Biopharma

Reistone Biopharma is a clinical-stage biopharmaceutical company that develops medicines for autoimmune and inflammatory diseases. The company has a particular focus on inflammatory bowel disease.

Founded in January 2018, Reistone Biopharma operates in Shanghai and Beijing, China, and Boston, USA. The company is actively engaged in clinical trials, including a successful Phase 2 trial for its JAK inhibitor for patients with moderate-to-severe ulcerative colitis. In May 2022, the company announced the completion of a Series A financing round of nearly USD 100 million, led by Huagai Capital.

Reistone Biopharma's business model is centered on the research and development of novel drugs to address unmet medical needs in the autoimmune and inflammatory disease market. The company's primary clients are patients suffering from these conditions, and it operates within the global biopharmaceutical industry.

Source: Dealroom company data

At a glance

Status
Operational
Employees
65
Open positions
None listed
Dealroom signal
80.7/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing May 2022 $100M $400M Zero2IPO · Zhangjiang Haoheng · Hanne Capital · YUNION Healthcare Fund ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Reistone Biopharma website traffic

Latest recorded traffic for Reistone Biopharma is 710 monthly website visits, up 108.8% over the last three months. Reistone Biopharma's team grew 3.2% over the past year.

Latest monthly visits710 3-month web change+108.8% 1-year team growth+3.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Reistone Biopharma in the Huangpu ecosystem

Live from Dealroom

The Reistone Biopharma office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Huagai Capital
  • Zero2IPO
  • Zhangjiang Haoheng
  • Hanne Capital
  • YUNION Healthcare Fund
  • Capital Healthcare Fund
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇨🇳 China80%
🇺🇸 United States8%
🇨🇦 Canada4%
🇹🇼 Taiwan4%
🇬🇧 United Kingdom4%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Reistone Biopharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Reistone Biopharma’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.